Banner Default Image

Insights

Back to Insights
Blog Img

Movers & Shakers: Q1&Q2 - Market Access, HEOR & Commercial Strategy

In January 2021, Mantell Associates established an additional function which focuses on placing high-level Market Access, HEOR and Commercial Strategy professionals into Life Science Management Consultancies.

Since then, we have partnered with many businesses on the appointment of highly experienced professionals, from Consultant up to Partner within the EU & US. Over the past six months, there have been a number of key hires within this space. Below are a few examples…

Mark Chalmers, Partner

Moved to: Ernst & Young

Moved from: Guidehouse

Sector: Commercial Access & Strategy

Ernst & Young’s Consulting arm has been making huge strides in the Life Science Consulting space, particularly within Market Access across all levels. The hire of Mark Chalmers as Partner, Commercial Access in Dublin, Ireland, is a clear representation of EY's aggressive growth. Mark has a PhD in Pharmacology & Molecular Biology from the University of Cambridge and a BSc in Pharmacology with Industrial Experience from the University of Edinburgh. Mark brings global experience in healthcare systems and health technology assessments, with a deep knowledge of oncology, rare diseases, cell & gene-based therapies.

Douglas Foerster, SVP

Moved to: Eversana

Moved from: Santhera Pharmaceuticals

Sector: Pricing & Market Access

Eversana has been an obvious “one to watch” within the Life Science Management Consulting space over the past couple of years, having acquired many businesses and showing no sign of slowing down. While acquiring other businesses and covering more and more spaces, they have seen rapid growth in the Market Access space at the senior level, including the hire of Douglas Foerster as Senior VP of Pricing & Market Access. Having previously worked at Abbott, AbbVie and Novartis, Douglas has transitioned over to the Consulting space and is expected to continue driving forward the Eversana business.

Ken Walsh, SVP & Global Head

Moved to: Lifescience Dynamics

Moved from: Trinity

Sector: Market Access

Lifescience Dynamics have traditionally been known as a company focused on the Competitive Intelligence and Market Research space. However, with the hire of Ken Walsh as Senior Vice President and Global Head of Market Access, Lifescience Dynamics are expected to make huge moves in the Market Access arena in the coming years. Ken brings experience from top Pharma fromhis time working at GSK, as well as experience from a number of Consultancies including Guidehouse and Blueprint (prior to the Trinity acquisition) where he opened up their EU Market Access capabilities.

Bob Swann, Director

Moved to: Remap Consulting

Moved from: ICON

Sector: Market Access

Bob Swann has become a widely known name in the Market Access space, having previously been a leading member of Heron (Parexel) and ICON's Market Access teams. Bob's industry experience includes 14 years with 3M HealthCare in pharmaceutical sales, clinical research and drug delivery. Bob brings over 30 years healthcare industry and consultancy experience into his new role as Director of Market Access at Remap Consulting, where he joins the Directors to further expand their Market Access offerings. His expertise in developing global pricing and market access strategies will play an instrumental part in Remap's growth.

Robert Albarano, Partner

Moved to: Triangle Insights Group

Moved from: L.E.K. Consulting

Sector: Strategy

Triangle Insights Group, LLC, a premier Life Science Consulting firm based in New York, recently appointed Robert Albarano as Partner. Robert has experience working at both large pharmaceutical companies and emerging biotechnology firms, and brings 20+ years’ consulting experience to his new role, including pricing and market access, growth strategy and transaction support. Previously working at the likes of L.E.K. Consulting, IQVIA and Syneos Health, Robert's appointment to the senior leadership team at Triangle Insights Group, who have begun making huge moves within the Life Science Strategy space, is certainly one to watch.

A NOTE FROM OUR CEO: Alessandro Mantell

It is with great pride and excitement that Mantell Associates have launched our first ever ‘Movers & Shakers’, which has been designed to highlight some of the biggest moves across the Life Science & Pharmaceutical Industry within the first six months of 2021.

Anyone who has followed the Mantell Associates journey so far will see the great extent of the effort and care that we have invested into making Mantell Associates not just ‘another recruitment business’ but a truly specialist, high-level headhunting organisation. We focus on Senior level appointments and consulting services, but we strive to share market intelligence and industry relevant content, and to provide exposure for individuals and businesses through the Mantell Associates Network podcast, which has already featured 21 industry leaders. In this ‘Movers & Shakers’ we look at the high level leadership moves between January and June this year, in particular across CDMO Large Molecule, CDMO Small Molecule, Life Sciences, Medical Devices & Consultancies, Market Access, HEOR. The incredible people and businesses that we highlight in this particular ‘Movers & Shakers’ are not only those who changed role but rather those who, during an incredibly difficult time, saw an opportunity to make an impact on the world and those around them.

Thank you from all of the Mantell Associates team – we hope you enjoy it!